# British American Tobacco plc on track for FY guidance with strong H2 acceleration

- Link: https://www.directorstalkinterviews.com/british-american-tobacco-plc-on-track-for-fy-guidance-with-strong-h2-acceleration/4121159046
- Published: 2024-06-04T07:13:50+01:00
- Author: Amilia Stone

**[British American Tobacco plc](https://www.directorstalkinterviews.com/ftse-company/british-american-tobacco/bats.l)**(
[LON:BATS](https://www.directorstalkinterviews.com/company/british-american-tobacco/bats.l))
has announced its latest trading statement.

·      On track to deliver FY24 guidance with H1 delivery in line with our expectations

·      Expected H2 acceleration driven by the phasing of innovation in New Categories,
and the benefits of H1 investment in U.S. commercial actions and related wholesaler
inventory movements

·      We are driving a further improvement in New Category profitability^(1) through
our Quality Growth focus on a more balanced top-line and bottom-line delivery

·      In Combustibles, U.S. commercial plans continue to gain traction despite 
a challenging macro-economic backdrop; in AME and APMEA we gained volume and value
share, with robust H1 pricing

·      Good AME performance reflecting the benefit of our multi-category portfolio;
H2 weighted APMEA performance due to the phasing of New Category launches, and a
strong H1 comparator

·      Partial monetisation of our ITC stake enabled the initiation of a sustainable
share buy-back

·      Strong cash conversion with our leverage^(2) expected to be within our narrowed
target range of 2.0-2.5x by year-end 2024.

> **Tadeu Marroco, British American Tobacco plc Chief Executive**:
> “Our year-to-date performance is in line with our expectations, and we are on 
> track to deliver our guidance of low-single digit revenue and adjusted profit 
> from operations growth on an organic^(3), constant currency basis in 2024.
> As previously highlighted, we expect our performance to be second-half weighted,
> mainly driven by wholesaler inventory movements related to continued investment
> in our U.S. commercial actions, as well as the phasing of new launches. Our guidance
> also reflects ongoing macro-economic pressures, particularly in the U.S. market
> and continued lack of effective enforcement against the growing illicit vapour
> segment. As a result, we expect our H1 revenue and adjusted profit from operations
> to be down by low-single digits on an organic^(3), constant currency basis.
> We are sharpening our execution and making targeted investment choices to drive
> our medium-term sustainable growth algorithm. We are investing to sustainably 
> strengthen our U.S. business, accelerate innovation momentum, and enhance capabilities
> that support our strategic delivery.
> These investments will set the business up for a stronger future. While there 
> is still more to do, I am confident that our actions are working, and I am encouraged
> by our continued traction in U.S. Combustibles, initial performance of glo Hyper
> Pro and enhanced consumables in early launch markets as well as the continued 
> success of our non-tobacco range veo in Europe.
> Our focus on Quality Growth is starting to drive accelerating returns on more 
> targeted investments across all three New Categories, particularly HP and Modern
> Oral. As a result, we expect to deliver further improvement in New Category profitability
> ^(1) for both the first half and full year. 
> In addition, we continue to prioritise shaping a sustainable future and call for
> more appropriate regulation and enforcement of New Categories, particularly in
> the U.S. Vapour market.
> BAT is a highly cash generative business, and we are committed to continuing to
> reward shareholders with strong cash returns. I am pleased with our progress in
> enhancing financial flexibility driven by continued strong operating cash conversion
> and completion of the partial monetisation of our ITC stake, enabling the initiation
> of a sustainable share buy-back.
> Looking forward, we expect growing momentum in the second half, enabled by the
> investments we are making today. As we continue our journey towards building a
> Smokeless World, guided by our refined strategy, we will progressively improve
> our performance to deliver 3-5% revenue, and mid-single digit adjusted profit 
> from operations growth on an organic^(3) constant currency basis by 2026.”

**Our outlook is underpinned by the following three key areas, where we are making
tangible progress:**

**1. Combustibles: U.S. commercial actions gaining traction; volume & value share
gains in AME & APMEA**

Group cigarette volume share in key markets^(4) is up 30 bps. Value share is down
10 bps mainly due to adverse geographical mix and the implementation of commercial
plans in the U.S.

While the U.S. macro environment is showing some early signs of recovery, consumers
remain stretched, with combustibles industry volume down c.9% YTD. As previously
highlighted, we expect our H1 performance to be impacted by continued investment
in our commercial actions and related phasing of wholesaler inventory movements,
with the latter expected to unwind in H2. We have now completed the majority of 
our previously announced commercial initiatives, which continue to gain traction,
including:

·      Strong performance of Newport soft-pack in key investment states, which together
with further share gains in Natural American Spirit, has driven our volume share
of the premium segment up 40 bps; and

·      Lucky Strike continues its strong growth record, maintaining its position
as the fastest growing combustibles brand in the U.S., with the branded value segment
now gaining volume share and deep discount share gains slowing.

We have continued to deliver robust pricing, value and volume share gains in AME
and APMEA. Key markets driving H1 financial delivery include Germany, Romania, Pakistan
and Mexico.

**2. Strengthening innovation driving New Category momentum**

**2.1 Vuse:** **Continued global value share leadership^(5); U.S. illicit single-
use vape headwinds persist**

We maintained global value share leadership at 41.1% in key markets^(6), with gains
in AME (up 20 bps) offset by the U.S. (down 90 bps).

In the U.S. we maintained value share leadership in tracked channels at 51.5%, however
we expect that our financial performance will be impacted by the continued growth
of illicit single-use vapes.

We continue to call for more appropriate regulation and enforcement to tackle illicit
products in the category, and we welcome signs of increasing action, including:

·      Proposed vapour directory and enforcement bills in 20 states, enacted in 
3 states to date; and

·      Encouraging early signs of illicit products volume decline in Louisiana, 
the first state to implement a vapour directory and enforcement legislation in October
2023, with Vuse Alto capturing the majority of the volume outflow back into the 
legal segment.

Our value share performance in AME was driven by France, Germany and Poland. More
broadly in AME, we are seeing continued poly-usage^(7) benefiting the vapour category.

This month, we are starting to roll out our new single-use vapour product, Vuse 
Go 2.0, featuring enhanced taste and design, and a removable battery, with substantial
further roll-outs planned through the remainder of 2024. As a result, in combination
with further innovation roll-outs under the closed system format, we expect an accelerating
volume and revenue performance in H2.

**2.2 glo:** _ _**Innovation pipeline starts to drive category volume share recovery
across key markets^(8)**

glo has started to deliver sequential category volume share improvement since January
in key markets^(8), with year-to-date volume share down 20 bps to 16.8% (versus 
down 110 bps in 2023), driven by encouraging early consumer response to our new 
innovations glo Hyper Pro and improved consumables. glo Hyper Pro is an important
first step into the premium HP segment, with comparable price positioning to other
premium products.

·      Category volume share stabilisation versus the prior year in our focus markets
of Japan and Italy

·      Continued strong performances in key AME markets, Poland and Czech Republic

·      veo, our non-tobacco consumables range, now launched in 17 markets, strongly
outperforming competing products with further roll-outs planned through the remainder
of the year.

We expect our H1 volume and revenue performance to be impacted by a stronger comparator
relating to our price repositioning in Japan and Italy in mid-2023, and the phased
roll-out of our newest innovations which will be completed across our key markets
by the end of H1.

As a result, we expect our positive share momentum to continue, and to drive an 
improving organic^(3) volume, revenue and profit^(1) performance in H2.

**2.3 Velo:** **Strong revenue and profit growth – continued leadership outside 
the U.S.**

Velo’s volume share of Total Oral in key markets^(9) is up 80 bps at 10.3%, driven
by strong Modern Oral category growth.

Our volume share of Modern Oral was down 10 bps to 27.0% in key markets^(9), mainly
driven by the weight of the U.S. market.

·      In AME we maintained our leadership position, reflecting our strength in 
both established oral markets like Sweden, Denmark and Norway, and our strong momentum
in newer launch markets including the UK and Poland

·      In the U.S. we are encouraged by early results from the phased roll-out of
our refreshed Velo brand expression, with volume share of Modern Oral stabilising
at 4.5%, driven by 13.5% volume share in our New York pilot, up 280 bps

·      In addition, following positive consumer testing, we have started to roll
out Grizzly Modern Oral nationally in the U.S., building on the growing trend of
Traditional Oral consumers moving to Modern Oral

We also see significant opportunity for Velo in emerging markets, with continued
strong volume performances in Pakistan and South Africa.

As a result, we expect Velo to continue to deliver a strong financial performance
in H1 and FY24.

**3. Enhancing financial flexibility**

BAT is a highly cash generative business, and we expect to deliver operating cash
flow conversion in excess of 90% again in 2024, enabled by our continuous improvement
mindset and further optimising resource allocation.

In March, we completed the monetisation of a 3.5% portion of our ITC stake, enabling
the initiation of a sustainable share buy-back, starting with £700m in 2024 and 
£900m in 2025.

We are making good progress on deleverage and expect to be within our narrowed leverage
target range of 2.0-2.5x adjusted net debt / adjusted EBITDA^(2) by year-end 2024.

**Technical guidance for full year 2024:**

·      Global tobacco industry volume expected to be down c.3%

·      Low-single figure organic^(3) constant currency revenue growth, with H2 weighted
New Category growth

·      Low-single figure organic^(3) adjusted profit from operations growth, including
a c.2% transactional FX headwind

·      H2 weighted Group revenue and profit growth

·      Translational FX headwind on adjusted profit from operations growth is expected
to be c.4% for half year and c.4% for full year^(10)

·      Operating cash flow conversion in excess of 90%

**Webcast and Conference call – The conference call will begin at 8.30am (BST)**

You can access the audio webcast via our website. You can also listen via conference
call by dialling the numbers below. Quote the password ‘BAT trading update’ when
prompted by the operator.

UK Toll-Free: 0808 109 0700

UK-Toll: +44 (0) 33 0551 0200

South Africa Toll-Free: +27 80 098 0512

USA Toll-Free: +1 866 580 3963

USA Toll: +1 786 697 3501

A playback facility for the conference call will be available online via British
American Tobacco’s website: www.bat.com.

Share on:
